IRCE is involved in the study of the uses and effects of drugs in defined populations particularly in people living with HIV/AIDS; and in the development of pharmacovigilance systems for four sub-Saharan African countries including Nigeria, Tanzania, Swaziland and Ethiopia. Our research in pharmacoepidemiology is often in collaboration with the National Agency for Food and Drug Administration and Control (NAFDAC), Nigeria